Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.70
-0.05 (-0.87%)
At close: Nov 22, 2024, 4:00 PM
5.80
+0.10 (1.75%)
After-hours: Nov 22, 2024, 7:59 PM EST
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.63 billion as of November 22, 2024. Its market cap has increased by 37.14% in one year.
Market Cap
1.63B
Enterprise Value
1.30B
1-Year Change
37.14%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since the IPO on April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $2.92B to $1.63B, a decrease of -43.98%. That is a compound annual growth rate of -14.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.80B | -15.80% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -0.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 1.72B |
| Xencor | 1.69B |
| Clover Health Investments | 1.68B |
| Galapagos NV | 1.66B |
| GoodRx Holdings | 1.65B |
| Dynavax Technologies | 1.62B |
| 10x Genomics | 1.61B |
| Immunocore Holdings | 1.61B |